Literature DB >> 11454986

Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders.

M Allen1, A Ishida-Yamamoto, J McGrath, S Davison, H Iizuka, M Simon, M Guerrin, A Hayday, R Vaughan, G Serre, R Trembath, J Barker.   

Abstract

SUMMARY: Corneodesmosin (Cdsn) is a late differentiation epidermal glycoprotein putatively involved in keratinocyte adhesion. The Cdsn gene lies within the susceptibility region on chromosome 6p21.3 (PSORS1) for psoriasis, a common chronic disfiguring skin disease. A particular allelic variant of Cdsn has a strong association with psoriasis. Therefore, genetically and biologically, Cdsn is a possible candidate gene for psoriasis susceptibility. To investigate a potential role for Cdsn in psoriasis pathogenesis, protein expression studies were performed by quantitative immunohistochemistry on normal skin, psoriatic skin (lesional and nonlesional), and other skin disorders using monoclonal antibodies (G36-19 and F28-27). In normal and nonlesional skin, Cdsn was expressed in stratum corneum and one or two layers of superficial stratum granulosum. In lesional psoriasis, there was a significant increase in Cdsn expression, which was observed in multiple layers of stratum spinosum and in stratum corneum. The expression pattern varied from granular, cytoplasmic immunoreactivity to cell surface labeling with weakly immunoreactive cytoplasm. In chronic atopic dermatitis, lichen planus, mycosis fungoides, and pityriasis rubra pilaris, Cdsn immunoreactivity was confined to stratum corneum and upper stratum granulosum with no stratum spinosum immunoreactivity. Immunoelectron microscopy of normal and lesional psoriatic skin demonstrated Cdsn release concomitant with involucrin incorporation into cell envelopes and completed before mature envelope formation. Extracellular release of Cdsn occurred at a lower level of the epidermis in psoriasis than normal skin. These protein expression studies provide evidence of altered Cdsn expression in psoriasis consistent with a role of Cdsn in disease pathogenesis. Further functional and genetic studies of Cdsn are justified to determine its role as a potential psoriasis-susceptibility factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454986     DOI: 10.1038/labinvest.3780309

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.

Authors:  Rajan P Nair; Philip E Stuart; Ioana Nistor; Ravi Hiremagalore; Nicholas V C Chia; Stefan Jenisch; Michael Weichenthal; Gonçalo R Abecasis; Henry W Lim; Enno Christophers; John J Voorhees; James T Elder
Journal:  Am J Hum Genet       Date:  2006-03-31       Impact factor: 11.025

2.  Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR.

Authors:  Cynthia Helms; Nancy L Saccone; Li Cao; Jil A Wright Daw; Kai Cao; Tony M Hsu; Patricia Taillon-Miller; Shenghui Duan; Derek Gordon; Brandon Pierce; Jurg Ott; John Rice; Marcelo A Fernandez-Vina; Pui-Yan Kwok; Alan Menter; Anne M Bowcock
Journal:  Hum Genet       Date:  2005-10-19       Impact factor: 4.132

Review 3.  New insights into the pathogenesis and genetics of psoriatic arthritis.

Authors:  Kristine E Nograles; Richard D Brasington; Anne M Bowcock
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

Review 4.  Psoriasis and other complex trait dermatoses: from Loci to functional pathways.

Authors:  Francesca Capon; A David Burden; Richard C Trembath; Jonathan N Barker
Journal:  J Invest Dermatol       Date:  2011-12-08       Impact factor: 8.551

5.  A Case of Acrodermatitis Continua of Hallopeau Following Chronic Pustular Cheilitis.

Authors:  Mariachiara Arisi; Maria Teresa Rossi; Raffaella Sala; Giulia Petrilli; Daniela Marocolo; Marco Ungari; Fabio Facchetti; Pier Giacomo Calzavara-Pinton
Journal:  Dermatol Ther (Heidelb)       Date:  2016-02-26

6.  Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population.

Authors:  Xing Fan; Sen Yang; Wei Huang; Zhi-Min Wang; Liang-Dan Sun; Yan-Hua Liang; Min Gao; Yue-Qing Ren; Kai-Yue Zhang; Wen-Hui Du; Yu-Jun Shen; Jian-Jun Liu; Xue-Jun Zhang
Journal:  PLoS Genet       Date:  2008-03-21       Impact factor: 5.917

Review 7.  Lifting the silver flakes: the pathogenesis and management of chronic plaque psoriasis.

Authors:  Heng T Chong; Zlatko Kopecki; Allison J Cowin
Journal:  Biomed Res Int       Date:  2013-08-25       Impact factor: 3.411

8.  Intense THz pulses down-regulate genes associated with skin cancer and psoriasis: a new therapeutic avenue?

Authors:  Lyubov V Titova; Ayesheshim K Ayesheshim; Andrey Golubov; Rocio Rodriguez-Juarez; Rafal Woycicki; Frank A Hegmann; Olga Kovalchuk
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  HLA-C*06:02-independent, gender-related association of PSORS1C3 and PSORS1C1/CDSN single-nucleotide polymorphisms with risk and severity of psoriasis.

Authors:  Andrzej Wiśniewski; Łukasz Matusiak; Aneta Szczerkowska-Dobosz; Izabela Nowak; Piotr Kuśnierczyk
Journal:  Mol Genet Genomics       Date:  2018-03-27       Impact factor: 3.291

Review 10.  The Epidermis: Redox Governor of Health and Diseases.

Authors:  Yosuke Ishitsuka; Dennis R Roop
Journal:  Antioxidants (Basel)       Date:  2021-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.